CannLabs, Inc. (CANL) Stock
CannLabs, Inc. provides cannabis testing laboratory services in the United States.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About CannLabs, Inc.
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
CannLabs, Inc. (CANL) stock trades at $0.00 with a market capitalization of $93317. The stock is valued at a price-to-earnings (P/E) ratio of 0.09, price-to-book of 0.01, price-to-sales of 0.02. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.
On profitability, CannLabs, Inc. generates a return on equity (ROE) of 50.00% — well above the market average, a sign of a high-quality business, return on capital employed of 27.67%, an operating margin of -259.18%, a net profit margin of -96.18%.
Official website: www.cannlabs.net